Role of Ayurveda in Covid 19 management.

A comparative clinical study to involving Ayurvedic drug intervention in the management of COVID 19 patients.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/025800

Enrollment

120

Registered

2020-06-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Shunthi and Rasona (Group B): Shunthi churna 2 gm twice daily for 10 days Rasona kalka 1 gm once daily with warm water for 10 days Intervention2: Kashaya Group (Group A): Vyaghryadi kas

Eligibility

Inclusion criteria

Inclusion criteria: Patients tested Positive for COVID 19. Asymptomatic Patients or with Mild Symptoms. Those willing to give informed Consent.

Exclusion criteria

Exclusion criteria: Patients below 25 years and above 60 years of age. Patients presenting with increased severity of disease. Those having serious Comorbidities, including Diabetes, Hypertension. Pregnant Women those not willing to give consent

Design outcomes

Primary

Measure	Time frame
To reduce Virus Clearance Time. To improve General Quality of Life. To minimise the chances of Disease progression in terms of Severity. To assess role of Ayurveda medicines in the COVID 19 Pandemic management. To establish Ayurvedic drugs role in National programme for COVID managementTimepoint: 5 days and 10 days	—

Secondary

Measure	Time frame
To ascertain role of Ayurveda in the National management of COVID 19 PandemicTimepoint: 5 days and 10 days	—

Countries

India

Contacts

Public ContactAdil Rais

LokBandhu Rajnarayan Combined Hospital

adil.rais13@gmail.com7060272769

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 16, 2026